At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best. Progress in Mind is Lundbeck’s dedication to addressing the global burden of brain diseases.
Our foundation for progress
Brain diseases are defined as a global health problem.1 Through improved medical treatments and continuous focus on the unmet needs of patients, we want to address the issue and call for greater awareness of the massive economic and societal burden brain diseases represent.
With our unique position as a specialist in psychiatry and neurology, we want to raise disease awareness and challenge the international agenda for broader acceptance of patients and increased opportunities for better treatment.
Far too many people suffer from brain diseases. At Lundbeck, we ask why...
|Why do almost 50% of people with brain diseases not receive any treatment?2
|Why should people with brain diseases live 10-20 years less than others?3
|Why do more than 70% of people living with brain diseases experience discrimination?4
|Why is it that 90% of all suicide victims suffered from a brain disease?5
Global progress for people living with brain diseases requires a multifaceted approach. First and foremost, we continue to develop new and improved medical treatments and continue to focus on the patient, ensuring that he or she regains possibilities. But we also work to embrace our purpose from two other essential dimensions: We encourage increased support to affected families and we engage in communities to create broader social acceptance of patients.
To raise awareness and prevent stigmatization, we use our voice as specialists in psychiatry and neurology and share our knowledge about the many unmet needs in the treatment of brain diseases. We reach into both professional and patient communities to offer disease education and support programs to healthcare professionals, patients and their families. Our global presence enables us to let successful, local initiatives travel the world and make a difference to patients everywhere.
Our R&D commitment
Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with brain diseases. We are specialists in our area and have a state-of-the-art research centers in Denmark and the US. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Together with our partners, we make our drugs available across continents for the benefit of millions of patients.
Meeting unmet needs of patients
Our specialists develop new drugs on the basis of deep insight into the brain, the specific diseases, and into the unmet needs of the patients. In order to create successful treatments, a dedication to the patient and his or her specific needs is crucial and precedes any development phase in Lundbeck’s R&D commitment. Understanding patients’ treatability and individual disease progression, as well as experienced symptoms, and side effects to current treatments, represents the most important driving force behind Lundbeck’s neuroscience research and enables us to develop tomorrow’s drug.
- WHO Quality Rights Project – addressing a hidden emergency, 2011
- Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Schizophr Res. 2000;45(1–2):21–8
- http://blog.ted.com/2012/09/11/some-stats-on-the-devastating-impact-of-mental-illness-worldwide-followed-by-some-reasons-for-hope/, https://www.time-to-change.org.uk/news/your-experiences-stigma-%E2%80%93-what-you-told-us
- https://www.nami.org/Learn-More/Mental-Health-Conditions/Related-Conditions/Suicide, https://www.who.int/mental_health/suicide-prevention/world_report_2014/en/, https://www.cambridge.org/core/journals/psychological-medicine/article/psychological-autopsy-studies-of-suicide-a-systematic-review/49EEDF1D29B26C270A2788275995FDEE